Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives [Yahoo! Finance]
Portage Biotech Inc. (PRTG)
Company Research
Source: Yahoo! Finance
immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy and in combination, today reported that it is expanding its evaluation of strategic alternatives and implementing additional measures to extend its available cash runway. After a review of the Company's future funding needs for clinical development of its adenosine antagonist platform as well as the current capital raising market for the Company, the Board of Directors has made the decision to pause further enrollment in the ADPORT-601 clinical trial of PORT-6 (adenosine 2A inhibitor) and PORT-7 (adenosine 2B inhibitor). The Company will explore strategic alternatives, which may include finding a partner for one or more of its assets, a potential sale of one or more of its assets, a sale of the Company, a merger, restructurings, both in and out of court, company wind down or other strategic action. There can be no assurance that the evaluation of strategic alternatives will result in any agreem
Show less
Read more
Impact Snapshot
Event Time:
PRTG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PRTG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PRTG alerts
High impacting Portage Biotech Inc. news events
Weekly update
A roundup of the hottest topics
PRTG
News
- Portage Biotech Announces Plans to Expand its Evaluation of Strategic AlternativesGlobeNewswire
- Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares [Yahoo! Finance]Yahoo! Finance
- Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) sharesGlobeNewswire
- Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business Update [Yahoo! Finance]Yahoo! Finance
- Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business UpdateGlobeNewswire
PRTG
Earnings
- 8/30/23 - Miss
PRTG
Sec Filings
- 4/12/24 - Form 424B3
- 4/12/24 - Form 6-K
- 3/8/24 - Form 424B3
- PRTG's page on the SEC website